Document is current
Any future updates will be listed below
-
Authors
Floris, Dorothea L. https://orcid.org/0000-0001-5838-6821
Llera, Alberto
Zabihi, Mariam
Moessnang, Carolin
Jones, Emily J. H.
Mason, Luke
Haartsen, Rianne https://orcid.org/0000-0003-1072-4152
Holz, Nathalie E. https://orcid.org/0000-0002-6225-9267
Mei, Ting https://orcid.org/0000-0003-3029-4460
Elleaume, Camille
Vieira, Bruno Hebling https://orcid.org/0000-0002-8770-7396
Pretzsch, Charlotte M. https://orcid.org/0000-0002-2761-6628
Forde, Natalie J.
Baumeister, Sarah https://orcid.org/0000-0001-9005-0084
Dell’Acqua, Flavio
Durston, Sarah
Banaschewski, Tobias https://orcid.org/0000-0003-4595-1144
Ecker, Christine
Holt, Rosemary J.
Baron-Cohen, Simon https://orcid.org/0000-0001-9217-2544
Bourgeron, Thomas
Charman, Tony https://orcid.org/0000-0003-1993-6549
Loth, Eva https://orcid.org/0000-0001-9458-9167
Murphy, Declan G. M. https://orcid.org/0000-0002-6664-7451
Buitelaar, Jan K. https://orcid.org/0000-0001-8288-7757
Beckmann, Christian F.
,
Holz, Nathalie E.
Forde, Natalie J.
Banaschewski, Tobias
Langer, Nicolas
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (101025785)
Simons Foundation (10039678, 10039678)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (10001C_197480)
Wellcome Trust (098369/Z/12/Z)
Templeton World Charity Foundation
Autism Research Trust NIHR Biomedical Research Centre in Cambridge
DH | National Institute for Health Research
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (602805; 603016; 278948, 864.12.003)
Innovative Medicines Initiative (115300; 777394)
- License Information
-
More Information
Article History
Received: 9 February 2024
Accepted: 7 October 2024
First Online: 2 January 2025
Competing interests
: J.K.B. has been a consultant to, advisory board member of and a speaker for Takeda/Shire, Medice, Roche and Servier. He is not an employee of any of these companies and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, or royalties. C.F.B. is director and shareholder in SBGneuro Ltd. T.C. has received consultancy fees from Roche and Servier and received book royalties from Guildford Press and Sage. T. Banaschewski served in an advisory or consultancy role for ADHS digital, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche and Takeda. He received conference support or speaker’s fees from Medice and Takeda. He received royalities from Hogrefe, Kohlhammer, CIP Medien and Oxford University Press; the present work is unrelated to these relationships. The other authors declare no competing interests.
